Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Leading BioSciences cleared to begin phase II study of LB-1148 in septic shock

Feb. 5, 2015

Researchers in Japan disclose humanized anti-HMGB1 MAbs

Aug. 25, 2014

AVEO Pharmaceuticals presents new anti-GDF-15 MAbs

July 18, 2014

Previously identified RIP1 kinase inhibitor potentially useful for necroptosis

Jan. 24, 2014

P2X1 receptor revealed as a target in transfusion-related acute lung injury

Aug. 6, 2013

Novel autotaxin inhibitors reported by Pfizer

May 23, 2013

Model of hyperoxic injury shows adaptive changes against infection and ROS

Jan. 31, 2013

Novel vitamin E derivative suppresses oxidative stress in animal models of traumatic injury

Jan. 25, 2013

New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus

Nov. 20, 2012

Pacific Therapeutics reports encouraging phase I results with combination treatment for fibrosis

Nov. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...